Intriguingly, the model is also strongly dependent on the IL-23/IL-17 axis, which has been identified as a critical molecular pathway in human psoriasis and which has become the most effective therapeutic target in the treatment of this disease [1, 14, 25]. The gene discussed is IL17A; the disease is psoriasis.